Investment in Equity Method Investments (Tables)

9 Months Ended

Sep. 30, 2016

Equity Method Investments and Joint Ventures [Abstract]

Summary of carrying amounts of assets and fair value of liabilities included in Condensed Consolidated Balance Sheet and maximum loss exposure in VIE

The following table summarizes the carrying amounts of the assets and liabilities included in the Company’s consolidated balance sheets and the maximum loss exposure related to the Company’s interest in the Solazyme Bunge JV as of September 30, 2016 and December 31, 2015 (in thousands):



	As of September 30, 2016
	Assets						Liabilities
	Accounts Receivable		Unbilled Revenues		Investments in Unconsolidated Joint Ventures		Loan Guarantee		Maximum Exposure to Loss⁽¹⁾
Equity investment - Solazyme Bunge JV	$	12	$	563	$	35,959	$	—	$	47,703



	As of December 31, 2015
	Assets						Liabilities
	Accounts Receivable		Unbilled Revenues		Investments in Unconsolidated Joint Ventures		Loan Guarantee		Maximum Exposure to Loss⁽²⁾
Equity investment - Solazyme Bunge JV	$	12	$	839	$	35,910	$	—	$	45,692


⁽¹⁾	Includes maximum exposure to loss attributable to the Company’s bank guarantee required to be provided for the Solazyme Bunge JV of $10.9 million and non-cancelable purchase obligations of $0.3 million (based on the exchange rate at September 30, 2016).

⁽²⁾Includes maximum exposure to loss attributable to the Company’s bank guarantee required to be provided for the Solazyme Bunge JV of $8.9 million (based on the exchange rate at December 31, 2015).

Summarized financial information on Solazyme Bunge JV's Balance Sheets and Income Statements

Summarized information on the Solazyme Bunge JV’s balance sheets and income statements as of September 30, 2016 and December 31, 2015, and for the three and nine months ended September 30, 2016 and 2015 respectively, was as follows (in thousands):



	As of September 30, 2016		As of December 31, 2015
Current assets	$	13,829	$	5,654
Property, plant and equipment, net	114,991		100,755
Recoverable taxes⁽¹⁾	20,852		16,144
Total assets	$	149,672	$	122,553

Current liabilities	$	41,929	$	23,009
Noncurrent liabilities	42,966		43,054
JV’s partners’ capital, net	64,777		56,490
Total liabilities and partners’ capital, net	$	149,672	$	122,553

⁽¹⁾Recoverable taxes are comprised of value-added taxes paid upon the acquisition of property, plant and equipment items and other goods and services, and other transactional taxes which can be recovered in cash or as compensation against income taxes or other taxes owed by the Solazyme Bunge JV in Brazil. The realization of these recoverable tax payments could take in excess of five years.



	Three months ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Net sales	$	2,495		$	953		$	5,491		$	1,611
Net losses	$	(12,357	)	$	(11,435	)	$	(32,036	)	$	(34,610	)

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details